UC San Francisco researchers have designed a candidate drug that could help make pancreatic cancer, which is almost always fatal, a treatable, perhaps even curable, condition.
Mar 5, 2024
0
38
Weizmann Institute scientists have discovered two small molecules that can cross the blood-brain barrier in mice, slowing and even reversing the effects of Huntington's, which is incurable.
Feb 26, 2024
0
40
Antibodies that can disarm a virus, known as neutralizing antibodies, are key to the body's ability to fight off infection. MIT chemists have come up with a new way to identify these neutralizing antibodies in a blood sample, ...
May 10, 2023
0
24
A study published this month in Science Advances by a team of researchers at Macquarie University's Dementia Research Center showed their treatment could prevent seizures in mice by clearing build‑ups of a protein in the ...
Dec 14, 2022
0
127
Like many neurological diseases, there's a lot we don't understand about fragile X syndrome. But, after studying the disorder for several years, Lynne Maquat's lab knew two important things: the enzyme AKT, which plays a ...
Jun 28, 2022
0
30
A research team at Aarhus University has developed a new molecule that attaches to the surface of SARS-CoV-2 virus particles. This attachment prevents the virus from entering human cells and spreading the infection.
Dec 13, 2021
0
1018
An international team of scientists and pharmaceutical collaborators has made a breakthrough "bench to bedside" discovery, ten years in the making, which they hope will advance the future treatment of Alzheimer's disease ...
Nov 26, 2021
0
79
Structural biologists at St. Jude Children's Research Hospital have determined the detailed structure of an enzyme whose mutated forms are known to cause Parkinson's disease. The achievement opens a research pathway to develop ...
Jun 9, 2021
0
14
Reactive oxygen molecules, also known as "free radicals," are generally considered harmful. However as it now turns out, they control cellular processes, which are important for the brain's ability to adapt—at least in ...
Dec 4, 2020
0
580
A research team led by Leonor Saúde, Principal Investigator at Instituto de Medicina Molecular (iMM; Lisbon, Portugal), in partnership with the company Technophage SA, has designed a simple and efficient platform that uses ...
Jul 19, 2019
0
54
